SLDBSolid Biosciences Inc.
$6.82+23% 1Y
$6.82
$3.9352 weeks$11.15
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Rangebound, no clear trend. Oversold (RSI 19). Price is −11% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SLDB is trading
Solid Biosciences Inc. is +23% over the past year while the S&P 500 is +18%: 5.2 points ahead of the market.
+23%
1-year return · S&P 500 +18%
- vs 200-day average
- −11%
vs 200-day average · a clear downtrend
- RSI (14)
- 19
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 39%
Below its 52-week high
Details›
- Last close2026-10-08
- $6.82
- 1 monthS&P 500 +1.6%
- −29%
- 1 yearS&P 500 +18%
- +23%
- 5 yearsS&P 500 +86%
- −81%
- vs 50-day average$8.67
- −21%
- 52-week high
- $11.14
- 52-week low
- $3.93
- Annualised volatility
- 90%
| Year | Return |
|---|---|
| 2026 (year to date) | +21% |
| 2025 | +41% |
| 2024 | −35% |
| 2023 | +14% |
| 2022 | −80% |
| 2021 | −77% |
| 2020 | +70% |
| 2019 | −83% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 3 of 8 | −3.5% |
| Feb | 9 | 4 of 9 | +2.8% |
| Mar | 9 | 3 of 9 | −10% |
| Apr | 9 | 3 of 9 | −1.6% |
| May | 9 | 5 of 9 | +3.7% |
| Jun | 9 | 5 of 9 | +13% |
| Jul | 9 | 4 of 9 | +5.4% |
| Aug | 9 | 4 of 9 | +1.4% |
| Sep | 9 | 3 of 9 | −8.8% |
| Oct | 9 | 2 of 9 | −4.2% |
| Nov | 8 | 5 of 8 | −5.6% |
| Dec | 8 | 4 of 8 | +25% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.